Eitan Akirav, Ph.D. Email and Phone Number
Eitan Akirav, Ph.D. work email
- Valid
- Valid
Eitan Akirav, Ph.D. personal email
As a seasoned biotech leader with over 17 years of experience, I bring a unique blend of scientific innovation and business strategy to the biotechnology and healthcare sectors. My career spans top-tier academic institutions and leading biotech companies, where I’ve consistently driven growth, fostered innovation, and built cross-functional teams that deliver impactful results.At Cerba Research, I transformed the Global Biomarker Program, leading a geographically diverse team across Europe, APAC, and the USA to increase revenue. By establishing a robust pipeline, I secured the company's market position during the pandemic. At Enzo, I spearheaded the development of diagnostic platforms, enabling rapid COVID-19 testing at the pandemic's onset and providing solutions for women's health.Earlier in my career at NYU, I built and funded a groundbreaking autoimmunity research program, securing millions in funding, leading five clinical trials, and bringing innovative diagnostic assays to market. My research has been featured in prestigious journals like PNAS and Nature Immunology, showcasing my commitment to advancing science.Beyond my professional achievements, I served as a peer reviewer and advocate for organizations like JDRF and the National MS Society, where I contributed expert insights to advance research and funding initiatives. I am passionate about bridging the gap between scientific discovery and business application, creating meaningful solutions that drive both innovation and market success.Feel free to connect with me here on LinkedIn to discuss potential collaborations, partnerships, or opportunities to drive impactful innovation together.
Konkai Ventures
View-
Founder And CeoKonkai Ventures Jan 2024 - Present• Spearheaded the development of innovative healthcare investment strategies, new product positioning, and strategic business development services at Konkai Ventures.• Implemented cutting-edge approaches to drive growth and enhance market positioning within the healthcare industry.• Achieved significant revenue growth and market expansion through strategic partnerships and new product development initiatives. -
Scientific Advisory Board MemberKihealth 2023 - PresentSaint Augustine, Fl, UsKi-Health is committed to advancing a holistic approach to metabolic disease through novel diagnostics, products, and services is exciting! -
Director Of Business Development, Office Of Technology Development (Otd)Harvard University 2022 - 2024Cambridge, Massachusetts, Us* Identified market needs and advised on scientific advancements to create financially sound commercialization pathways, reducing risk and enhancing market readiness.* Established high-impact partnerships and secured optimal intellectual property agreements to maximize research impact and drive technology commercialization. -
Vice President Global Lead For BiomarkersCerba Research 2020 - 2021Ghent, Flemish Region, Be* Spearheaded strategic initiatives in corporate and business development, talent management, and biomarker innovation to drive revenue growth, expand market presence, and enhance diagnostic offerings through targeted partnerships and scientific expertise, including securing a multimillion clinical trial partnership in APAC and doubling sales team revenue within eight months.* Directed biomarker development from preclinical to clinical stages, ensuring rigorous therapeutic study requirements while aligning Cerba’s capabilities with evolving industry demands in immuno-oncology, cell-based therapies, and solid tumors, strengthening partnerships and delivering clinical milestones with precision. -
Assistant Professor Of ResearchStony Brook University 2011 - 2021Stony Brook, Ny, Us -
Director Corporate Business Development And Scientific Director Of Translational Science GroupEnzo Life Sciences, Inc. 2017 - 2019Farmingdale, Ny, Us* Directed the development of molecular diagnostics platforms, securing reagent supplies, managing compliance, and driving contract negotiations to position Enzo as a leading COVID-19 testing provider in NY and NJ during the pandemic. Oversaw the launch of FISH and IHC services and reagents, expanding diagnostic capabilities across U.S. and global markets while ensuring compatibility and supply chain efficiency.* Built a high-caliber business development team of Ph.D. professionals, driving scientific innovation and market expansion through strategic R&D initiatives in women’s health, STDs, and cervical cancer. Executed go-to-market strategies and ensured regulatory compliance (GMP, IVD/CE, FDA), enhancing Enzo’s adaptability and resilience amid industry challenges. -
Senior Principal Investigator/Lead Research ScientistWinthrop-University Hospital 2011 - 2017Mineola, Ny, Us* Pioneered the first biomarker using circulating-cell-free DNA to measure cell loss in diseases such as diabetes, multiple sclerosis, and Parkinson's disease, introducing a minimally invasive diagnostic method featured in PNAS and Newsday for its groundbreaking impact on hard-to-access tissues like the brain and pancreas.* Secured substantial funding from JDRF and the National MS Society, led IRB-approved clinical trials in collaboration with NYU, and directed multidisciplinary teams to publish high-impact findings in journals such as Nature Immunology and Journal of Biological Chemistry, advancing both scientific innovation and institutional prestige. -
Teaching AssistantYale University School Of Medicine 2004 - 2005New Haven, Ct, Us
Eitan Akirav, Ph.D. Skills
Eitan Akirav, Ph.D. Education Details
-
Yale School Of MedicineAutoimmunity And Diabetes -
Yale School Of MedicineImmunology -
Yale School Of MedicineImmunology -
University Of TorontoPhysiology And Endocrinology -
Tel Aviv UniversityBiology
Frequently Asked Questions about Eitan Akirav, Ph.D.
What company does Eitan Akirav, Ph.D. work for?
Eitan Akirav, Ph.D. works for Konkai Ventures
What is Eitan Akirav, Ph.D.'s role at the current company?
Eitan Akirav, Ph.D.'s current role is Dynamic Biotech Leader with a Dual Focus on Scientific Innovation and Business Strategy.
What is Eitan Akirav, Ph.D.'s email address?
Eitan Akirav, Ph.D.'s email address is ea****@****lab.com
What schools did Eitan Akirav, Ph.D. attend?
Eitan Akirav, Ph.D. attended Yale School Of Medicine, Yale School Of Medicine, Yale School Of Medicine, University Of Toronto, Tel Aviv University.
What are some of Eitan Akirav, Ph.D.'s interests?
Eitan Akirav, Ph.D. has interest in Multiple Sclerosis, Diabetes Research.
What skills is Eitan Akirav, Ph.D. known for?
Eitan Akirav, Ph.D. has skills like Immunology, Cell, Molecular Biology, Life Sciences, In Vivo, Cell Culture, Scientific Writing, Cell Biology, Diabetes, Biomarkers, In Vitro, Immunofluorescence.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial